A nonamer peptide from murine nicotinic acetylcholine receptor a chain (ACR8), which shared four amino acid residues with a nonamer peptide of murine ovarian zona pellucida glycoprotein ZP3, induced murine autoimmune oophoritis and IgG autoantibody to the zona pellucida. Crossreaction between the ACR5 and ZP3 peptides was established by the response of a ZP3 peptide-specific, oophoritogenic T cell clone to both peptides in association with 1A(d'#). By substituting the ZP3 peptides with a single alanine, four amino acids within the ZP3 peptide were found to be important for ovarian autoimmune disease, autoantibody response, and stimulation ofthe ZP3-specific T cell clone. Substitution with conservative amino acids of three residues also ablated activity, whereas the fourth, a phenylalanine, was replaceable by tyrosine without loss of activity. Of the four critical amino acids, three were shared between the ZP3 peptide and the ACR5 peptide. Moreover, polyalanine peptides with the four critical ZP3 amino acids or the four amino acids common to the ZP3 and ACR5 peptides induced immune response to ZP3 and elicited severe ovarian autoimmune disease. Thus, organ-specific autoimmune disease can occur through immune response against unrelated self (or foreign) peptides that share with a self-peptide sufficient common amino acid residues critical for activation of pathogenic, autoreactive T cells. (J. Clin. Invest. 1993Invest. . 92:2117Invest. -2123
Introduction
Antigen mimicry has long been proposed as a potential mechanism underlying organ-specific human autoimmune diseases ( 1). Idiopathic encephalitis, neuritis, and myelitis often occur after viral infection, and autoantibodies have been detected in these patients that react with neural antigens. Investigations in the past have focused on foreign antigenic determinants recognized by autoantibodies (2) . Although foreign antigens induced antibody responses that crossreacted with selfmolecules, autoimmune disease rarely developed in the immunized animals. There are some exceptions. For example, focal encephalomyelitis was induced in rabbits immunized with a peptide from hepatitis B virus; the viral peptide shared common sequence with, and provoked antibody against, the myelin basic protein (3) . Another was the induction of myasthenia gravis in rabbits immunized with a chemical analogue ofacetylcholine, through induction of antiidiotype antibody that crossreacted with the nicotinic acetylcholine receptor (ACR)' (4) .
Since activation of T cell response to self-peptides is a pivotal event in the pathogenesis of organ-specific autoimmune diseases, crossreaction between foreign and self-peptides recognized by T cells should, in principle, be more pertinent than autoantibodies in antigen mimicry (5) . We have therefore explored this possibility based on a model of murine ovarian autoimmune disease (oophoritis) elicited by a well-characterized ovarian peptide (6) .
ZP3 is a glycoprotein in the zona pellucida, its 0-linked oligosaccharide being the major sperm receptor in fertilization (7) . Within the murine ZP3 sequence (8) is a 13-mer ZP3 peptide (ZP3 330-342) that has two overlapping antigenic domains: ZP3 336-342, a 7-mer linear sequence recognized by ZP3 antibody (9) , and ZP3 330-337, the minimal octomer sequence that induces oophoritis, pathology transferrable by pathogenic CD4' T cells (6) . Murine autoimmune oophoritis is a model of human premature ovarian failure in which oophoritis and autoantibodies to ovarian antigens have been documented ( 10) . In addition, premature ovarian failure often coexists with autoimmune adrenalitis, autoimmune thyroiditis, and myasthenia gravis ( 11) . It is currently unclear as to why multiple autoimmune diseases should occur in the same individual. In this paper, we present evidence for antigen mimicry between the murine ZP3 peptide and a peptide from the murine ACR5 chain (ACR6). Mice immunized with the nonamer ACR6 peptide developed oophoritis and autoantibodies to the zona pellucida. The evidence for, and the mechanism underlying, the crossreaction between the ZP3 and the ACR5 peptides will be presented.
Methods
Induction ofmurine autoimmune oophoritis. Adult female (C57BL/6 X A/J)F, (B6AF1 ) mice were purchased from The Jackson Laboratory (Bar Harbor, ME) or the National Cancer Institute (Frederick, MD).
Each peptide (at 50-,ug dose, dissolved in deionized/distilled water) was emulsified in an equal volume of CFA containing 1 mg/ml of Mycobacterium tuberculosis (H37Ra; Difco Laboratories, Detroit, MI) or in incomplete Freund's adjuvant (ICFA). Each mouse received 0.1 ml of the peptide and adjuvant emulsion, distributed in the two hind footpads. Histologic evidence of autoimmune oophoritis was determined 14 d later.
Histology and immunohistochemistry. The ovaries fixed in the Bouin's fixative were embedded in paraffin. Approximately 50 serial step sections per ovary, 5 ,lm thick, were stained with hematoxylin and eosin. Histopathology ofoophoritis was evaluated as coded specimens, with severity graded from 1 to 4: 1, focal inflammation in interstitial space; 2 and 3, increasing multifocal inflammatory foci and/or granuloma between and within ovarian follicles; 4, loss of ovarian follicles and ovarian atrophy (6 Cytokine assays. IL-2, IL-4, tumor necrosis factor, and interferon y were quantitated as described elsewhere ( 13) .
Statistical analysis. Significance in disease incidence differences was determined by the chi-square analysis.
Results
A peptidefrom murineACR delta chain elicits murine autoimmune oophoritis. Among truncated ZP3 328-342 peptides, ZP3 330-338 was the shortest oophoritogenic peptide found to stimulate mitogenic response of an oophoritogenic T cell line (6) Fig. 1 B) , ofwhich many were T (CD3+) cells (Fig. 1 C) . The nature and the extent ofovarian histopathology in the ACRb 120-128-immunized mice resembled the mild to moderate oophoritis observed in mice immunized with ZP3 330-338 (6). Consistent with oophoritis induced by the ZP3 peptides, mice immunized with ACRb 120-128 in ICFA also developed ovarian autoimmune disease (6) (Table I) .
Although ZP3 330-338 stimulated the ZP3 330-342-specific T cell line to proliferate, T cells from regional lymph nodes of mice immunized with ZP3 330-338 did not proliferate against ZP3 330-338 in vitro (6) . We therefore generated an oophoritogenic, ZP3 330-342-specific T cell clone for purpose ofexploring T cell receptor recognition ofthe ZP3 peptide and the ACR5 peptide.
Production and characterization ofa murine ZP3 peptidespecific oophoritogenic T cell clone. From an oophoritogenic ZP3-specific T cell line (6), a ZP3 330-342-specific T cell clone (J3) was obtained by limiting dilution, twice, at 0.3 cells per well. The J3 clone was CD4+; upon activation, it produced IL-2, interferon y, and tumor necrosis factor, but not IL-4 (data not shown). As shown in Table II (Fig. 1 D) .
Because ZP3 330-338 is known to have T cell but not B cell epitope (1 Sa), induction of antibody to the zona pellucida by ZP3 330-338 or ACR5 120-128 was unexpected. Although we will defer a discussion on the basis for the unexpected autoantibody response to the Discussion section, the induction of T cell-dependent IgG antibody response to zona pellucida by ACRb 120-128 provides evidence for the crossreaction between ACRb 120-128 and ZP3 330-338 in stimulating helper T cell required for anti-zona pellucida IgG antibody response. Quantitative analysis of the IgG eluted from the ovaries also established that the zona-bound IgG in mice immunized with the ZP3 peptide was highly enriched ( -200-400) for antibody to the zona pellucida over serum IgG (1 Sa).
Studies ofZP3 330-338 peptides with a single alanine substitution. We next identified the amino acid residues in ZP3 330-338 important for induction of(a) autoimmune oophoritis, (b) anti-zona pellucida antibody, and (c) mitogenic response of the oophoritogenic T cell clone.
The ZP3 330-338 peptide in which the residue Asn 330, Gln 335, or Phe 336 was substituted by an alanine did not elicit autoimmune oophoritis (Table III , Study 1). The replacement of Gln 337 by alanine also reduced the oophoritogenic potential of ZP3 330-338 significantly (P = 0.01). Mice immunized with these four alanine-substituted ZP3 peptides likewise did not develop antibody to the zona pellucida (Table III) . However, when the other amino acid residues ofZP3 330-338 were each substituted by an alanine, the peptides retained their capacity to induce autoimmune oophoritis and zona pellucida antibody (P values ranged from 0.4 to 0.8) (Table III Here, we positively identify the amino acid residues in ZP3 330-338 and ACR5 120-128 that are sufficient to elicit au- We first studied the substituted polyalanine peptide, NAAAAQFQA, which contained the four amino acid residues in ZP3 330-338 shown by the single alanine scan to be important for inducing autoimmune oophoritis. B6AF1 mice immunized with the NAAAAQFQA peptide developed severe oophoritis and autoantibody to zona pellucida (Table III, Study  3) . We next studied the polyalanine peptide that contained the amino acids common to ZP3 330-338 and ACRb 120-128 (NAAAAAEQI). The NAAAAAFOI peptide also induced severe oophoritis and autoantibody response to the zona pellucida, and the ovarian pathology was actually more severe than those observed in mice immunized with ACRb 120-128. In parallel, the J3 clone responded vigorously to both NAAAAQFQA and NAAAAAFOI peptides (Table III, 
Discussion
This study has demonstrated that a nonamer peptide from mouse ACR5, which has four amino acid residues in common with a mouse ovarian ZP3 nonamer peptide, is recognized by a pathogenic ZP3 peptide-specific T cell clone, and the recognition was restricted by the same class II MHC molecule. Importantly, B6AF1 mice actively immunized with the ACRb peptide developed ovarian autoimmune disease. Their ovarian inflammatory infiltrates contained numerous T cells, and they developed autoantibody of the IgG class that bound to the zona portant for Induction ofAutoimmune Oophoritis and Anti-Zona The results ofthe in vivo experiments in studies 1 and 3 are pooled from two independent experiments; those of study 2 are from one experiment. The proliferative responses of the J3 clone to the various peptides are highly reproducible and the result of a representative experiment is shown.
pellucida in vivo. Of the four amino acids shared by the two unrelated selfpeptides, three were important for (a) activation of the oophoritogenic T cell clone, (b) induction of autoimmune oophoritis, and (c) development ofzona pellucida autoantibodies. To address the evidence for T cell mimicry directly, we studied a polyalanine peptide with the shared amino acid residues between the ACRb and the ZP3 peptides. We then compared this peptide with the polyalanine peptide that contained the four critical amino acid residues ofthe ZP3 peptide. Both substituted polyalanine peptides were as active as the nonamer ZP3 peptide with respect to oophoritis and autoantibody induction, and in stimulation ofthe oophoritogenic T cell clone. It would appear that the sharing of the three critical amino acid residues between the ZP3 and ACRb peptides might be the minimal requirement for oophoritis induction. The murine ACRy peptide, which had only two of the critical amino acid residues in common with the ZP3 peptide, did not induce disease or autoimmune responses to ZP3. We conclude that the ACRb peptide elicits ovarian autoimmune disease through activation ofZP3 330-338-specific pathogenic T The finding that ACRb 120-128 also has the capacity to induce autoantibody to the zona pellucida provides strong evidence that the ACR5 peptide is also recognized by, and can activate, ZP3 peptide-specific helper T cells. Even more important, it demonstrates clearly that mimicry strictly at the level of T cell epitope can lead to immunologic events beyond the induction ofT cell response and autoimmune disease. That is, T cell epitope mimicry alone can evoke an autoantibody response against the native protein antigen. Therefore, it is quite possible that research that focuses on autoantibodies could minimize or mask the importance of T cell-mediated immunity in organ-specific, and perhaps systemic, autoimmune disease. On the other hand, the zona pellucida autoantibodies in mice immunized with a T cell peptide of ZP3 preferentially reacted with the native determinants of ZP3 and were bound to the zona pellucida in vivo; thus they are potentially relevant in autoimmune disease pathogenesis (1 5a). We have recently uncovered antigen mimicry between ZP3 330-338 and exogenous antigenic peptides (Garza and Tung, preliminary findings). They include (a) a torpedo ACRy peptide, which shared three of the four critical amino acids with ZP3 330-338 but differs from murine ACRy 117-124 in one of these three amino acid residues, and (b) a viral peptide. Immunization of B6AF1 mice with each of these exogenous peptides led to autoimmune oophoritis and autoantibodies to the zona pellucida. Thus, the mechanism of antigen mimicry between ZP3 330-338 and ACRS 120-128 does not appear to be an isolated experimental observation.
We have not yet determined whether the critical amino acid residues in the ZP3 330-338 peptide are required for binding to IA(akfb) or as contact sites with the oophoritogenic T cell receptor. In this regard, the finding on the phenylalanine residue in ZP3 336 is of interest. The oophoritogenicity ofZP3 330-338 was lost when Phe 336 was replaced by alanine but not by tyrosine. We have since obtained evidence that the ZP3 peptide retained oophoritogenic activity when Phe 336 was replaced with hydrophobic but not polar amino acid residues (Garza and Tung, preliminary findings). Thus, Phe 336 may be critical by virtue ofthe chemical property required for interaction with the MHC molecule or the T cell receptor. The finding ofamino acid residues in T cell epitopes with functions replaceable by some but not other unrelated amino acids is not new ( 17) , and has also been documented in another self peptide of the myelin basic protein ( 18) .
Antigen mimicry has long been proposed as an event that might trigger human organ-specific autoimmune diseases ( 19). The possibility that autoimmune disease could be induced through antigen mimicry of T cell epitopes was initially documented in study on a peptide from a Escherichia coli protein. The peptide was found to share sequence homology with the S retinal protein, and rats immunized with the E. coli peptide led to autoimmune uveitis and T cell response to the S peptide (20) . However, the study neither established T cell cross-reaction between the peptides nor investigated the mechanism behind the observed phenomenon. Moreover, very large doses of the E. coli peptide (400-2,000 ,ug) were required to elicit eye pathology. Two recent studies have also explored T cell epitope mimicry by a novel approach. On the basis of the protocol that recreated the T cell epitopy of a ribonuclease peptide (2 1), polyalanine peptides were synthesized that contained the critical amino acid residues of the encephalitogenic peptide of the myelin basic protein ( 18, 22 ). These peptides not only stimulated proliferation of encephalitogenic T cell clone, they induced experimental autoimmune encephalomyelitis (EAE) as well.
The impetus behind our study was initially to elucidate the mechanism for concurrence of autoimmune ovarian disease and myasthenia gravis. Whereas antigen mimicry remains a potential mechanism behind multiple clinical autoimmune diseases, the recently published amino acid sequence ofhuman ZP3 has ruled out direct extrapolation of our experimental findings to the concurrence of the two human diseases (23).
The murine and human ZP3 330-338 sequences are highly variant, whereas their ACRb 120-128 sequences are identical.
This study has important implications for peptide vaccines from foreign proteins that elicit T cell responses, where, similar to experimental autoimmune disease induction, individuals would be vaccinated with a peptide (24) . On the basis of this and other studies ( 18, 22) , it is clear that molecular mimicry for autoimmune disease induction requires merely a few randomly positioned amino acid residues (< 50%) of a self-peptide. Therefore, the potential target self-peptides are not likely detectable by the vaccine peptide probes (antibody or oligonucleotide). Moreover, even ifthe critical amino acid residues in the vaccine peptide for T cell activation are known, to search for selftarget peptides with shared amino acid residues is experimentally difficult if not impossible. Finally, powerful adjuvants such as myobacterial components or pertussis toxin are not always required for induction of experimental autoimmune diseases. Although they are obligatory for induction of murine EAE (19) and murine experimental autoimmune orchitis (25), they are not required for murine autoimmune oophoritis (6) .
With respect to antigen mimicry in spontaneous autoimmune diseases, it may be argued that immune response to a small peptide does not represent a likely event by which the human disease is triggered. In responses against self proteins that are subjected to tolerance regulation, there is evidence that the pathogenic peptides within a self-protein may be cryptic. Their immunogenicity is manifested only when presented to the host as synthetic peptides and not as the natural sequences of the whole protein (26, 27) . However, this finding may not apply to responses against T cell epitopes in microbial protein antigens. Spontaneous immune response to microbial agents is complex; and infections, through unknown mechanisms, have been found to terminate an experimentally induced tolerance state (28) (29) (30) . Microbial superantigens may bypass the tolerance state by coactivating Vf3-specific self-reactive T cells (31) .
Therefore, whether a peptide in a microbe that mimics a self peptide can function as a potent immunogen during an infection remains to be determined experimentally.
